Assessment of the potential efficacy and CNS side-effects of novel serotonergic anti-obesity agents in Phase 1 clinical studies. Journal of Pharmacological Sciences 101, Suppl. 1, 17.

Dourish C.T., Boyland, E., Halford J.C.G., Dawson, G.R., Wilding, J.P.H. (2006)